Deep brain stimulation for Parkinson's disease

Current Opinion in Neurobiology

Volumn 13, Issue 6, 2003, Pages 696-706

  Benabid, Alim Louis ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

BASAL GANGLION; BRAIN DEPTH STIMULATION; BRAIN VENTRICULOGRAPHY; DEPRESSION; DIATHERMY; DISEASE ASSOCIATION; DRUG EFFECT; FOLLOW UP; GLOBUS PALLIDUS; HUMAN; MOOD; MOTOR ACTIVITY; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; REVIEW; SENSORIMOTOR CORTEX; SUBTHALAMIC NUCLEUS; THALAMOTOMY; TREMOR;

EID: 0345118159     PISSN: 09594388     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.conb.2003.11.001     Document Type: Review

References (87)

1. Starr P.A., Christine C.W., Theodosopoulos P.V., Lindsey N., Byrd D., Mosley A., Marks W.J. Jr. Implantation of deep brain stimulators into the subthalamic nucleus: technical approach and magnetic resonance imaging-verified lead locations. J Neurosurg. 97:2002;370-387.
2. Benabid A.L., Benazzouz A., Gao D.M., Hoffmann D., Limousin P., Koudsie A., Krack P., Pollak P. Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus and of other nuclei as a treatment for Parkinson's disease. Techniques in Neurosurgery. 5:1999;5-30.
3. Alterman R.L., Kall B.A., Cohen H., Kelly P.J. Stereotactic ventrolateral thalamotomy: is ventriculography necessary? Neurosurgery. 37:1995;717-721.
4. Cheshire W.P., Ehle A.L. Hemi-parkinsonism as a complication of an Ommaya reservoir. J Neurosurg. 73:1990;774-776.
5. Marks P.V., Wild A.M., Gleave J.R.W. Long-term abolition of Parkinsonian tremor following attempted ventriculography. Br J Neurosurg. 5:1991;505-508.
6. Abosch A., Hutchison W.D., Saint-Cyr J.A., Dostrovsky J.O., Lozano A.M. Movement-related neurons of the subthalamic nucleus in patients with Parkinson's disease. J Neurosurg. 97:2002;1167-1172 This study examines the distribution of movement-related neurons within the STN of 38 awake, non-sedated patients with PD to identify neuronal receptive fields. The receptive fields were identified in 278 (55%) of 510 STN neurons studied. Fourteen percent of cells tested positive for face receptive fields, 32% for upper-extremity receptive fields, and 21% for lower-extremity receptive fields. Twenty four percent demonstrated multiple-joint receptive fields. Sixty five percent with movement-related receptive fields were located in the dorsal half of the STN, and 96. 8% of these were located in the rostral two thirds of the STN. Analysis of receptive field locations failed to reveal a consistent somatotopic organization of fields within the STN, which supports the existence of specific motor territories within the STN in patients suffering from PD.
7. Benazzouz A., Breit S., Koudsie A., Pollak P., Krack P., Benabid A.L. Intraoperative microrecordings of the subthalamic nucleus in Parkinson's disease. Mov Disord. 17:2002;S145-S149.
8. Pollak P., Krack P., Fraix V., Mendes A., Moro E., Chabardes S., Benabid A.L. Intraoperative micro- and macrostimulation of the subthalamic nucleus in Parkinson's disease. Mov Disord. 17:2002;S155-S161.
9. Hariz M.I., Fodstad H. Do microelectrode techniques increase accuracy or decrease risks in pallidotomy and deep brain stimulation? A critical review of the literature. Stereotact Funct Neurosurg. 72:1999;157-169.
10. Tamma F., Caputo E., Chiesa V., Egidi M., Locatelli M., Rampini P., Cinnante C., Pesenti A., Priori A. Anatomo-clinical correlation of intraoperative stimulation-induced side-effects during HF-DBS of the subthalamic nucleus. Neurol Sci. 23:2002;S109-S110.
11. Benabid A.L., Pollak P., Gervason C., Hoffmann D., Gao D.M., Hommel M., Perret J.E., de Rougemont J. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet. 337:1991;401-406.
12. Benabid A.L., Pollak P., Gao D., Hoffmann D., Limousin P., Gay E., Payen I., Benazzouz A. Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. J Neurosurg. 84:1996;203-214.
13. Caparros-Lefebvre D., Blond S., Feltin M.P., Pollak P., Benabid A.L. Improvement of levodopa induced dyskinesias by thalamic deep brain stimulation is related to slight variation in electrode placement: possible involvement of the centre median and parafascicularis complex. J Neurol Neurosurg Psychiatry. 67:1999;308-314.
14. Siegfried J., Lippitz B. Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms. Neurosurgery. 35:1994;1126-1129.
15. Limousin P., Pollak P., Benazzouz A., Hoffmann D., Le Bas J.F., Broussolle E., Perret J.E., Benabid A.L. Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet. 345:1995;91-95.
16. Limousin P., Krack P., Pollak P., Benazzouz A., Ardouin C., Hoffmann D., Benabid A.L. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med. 339:1998;1105-1111.
17. The Deep-Brain Stimulation for Parkinson's Disease Study Group: DBS of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001, 345:956-963.
18. Charles P.D., Van Blercom N., Krack P., Lee S.L., Xie J., Besson G., Benabid A.L., Pollak P. Predictors of effective bilateral subthalamic nucleus stimulation for PD. Neurology. 59:2002;932-934.
19. Moro E., Esselink R.J., Benabid A.L., Pollak P. Response to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation. Brain. 125:2002;2408-2417.
20. Lagrange E., Krack P., Moro E., Ardouin C., Van Blercom N., Chabardes S., Benabid A.L., Pollak P. Bilateral subthalamic nucleus stimulation improves health-related quality of life in PD. Neurology. 59:2002;1976-1978 The authors assessed the impact of bilateral STN stimulation on quality of life in 60 patients with PD before and 12 months after surgery. All aspects of quality of life, including motor (-48%), systemic (-34%), emotional (-29%), and social (-63%) dimensions significantly improved with long-term STN stimulation. Patients were mildly depressed before surgery (BDI 10.4 ± 6.6) and there was a small but significant improvement of mood after surgery (BDI 8.5 ± 4.1, p < 0.002). Some aspects were dramatically improved, such as 'hobbies' (100%, but during 'off' periods 90%), whereas others were not, such as 'shuffling' or 'exhaustion'. The improvement in the score of the UPDRS III was correlated with the improvement in the total PDQL score, but not with the improvement in the BDI. The motor improvement may not reflect the therapeutic impact of the procedure. Social isolation, depression, and cognitive impairment may have a greater impact on quality of life in PD. Moreover, surgical side effects or cognitive, psychiatric, and behavioral side effects related to surgery, STN stimulation, or changes in medication could mitigate the positive effects measured by the scales that are mainly formed on the basis of motor symptoms.
21. Schuurman P.R., Bosch D.A., Bossuyt P.M., Bonsel G.J., van Someren E.J., de Bie R.M., Merkus M.P., Speelman J.D. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med. 342:2000;461-468.
22. Krack P., Fraix V., Mendes A., Benabid A.L., Pollak P. Postoperative management of subthalamic nucleus stimulation for Parkinson's disease. Mov Disord. 17:2002;S188-S197.
23. Moro E., Esselink R.J., Xie J., Hommel M., Benabid A.L., Pollak P. The impact on Parkinson's disease of electrical parameter settings in STN stimulation. Neurology. 59:2002;706-713.
24. Deuschl G., Wenzelburger R., Kopper F., Volkmann J. Deep brain stimulation of the subthalamic nucleus for Parkinson's disease: a therapy approaching evidence-based standards. J Neurol. 250:2003;I43-I46.
25. Tavella A., Bergamasco B., Bosticco E., Lanotte M., Perozzo P., Rizzone M., Torre E., Lopiano L. Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: long-term follow-up. Neurol Sci. 23:2002;S111-S112.
26. Rehncrona S., Johnels B., Widner H., Tornqvist A.L., Hariz M., Sydow O. Long-term efficacy of thalamic deep brain stimulation for tremor: double-blind assessments. Mov Disord. 18:2003;163-170.
27. Gentil M., Pinto S., Pollak P., Benabid A.L. Effect of bilateral stimulation of the subthalamic nucleus on parkinsonian dysarthria. Brain Lang. 85:2003;190-196 Speech is one of the symptoms that is improved to a lesser extent after DBS, and postoperative hypophonia is severely disabling. This study demonstrates, however, that STN DBS does improve the motor components of speech, although to a lesser extent than the motor function of the limbs.
28. Pinto S., Gentil M., Fraix V., Benabid A.L., Pollak P. Bilateral subthalamic stimulation effects on oral force control in Parkinson's disease. J Neurol. 250:2003;179-187.
29. Temperli P., Ghika J., Villemure J.G., Burkhard P.R., Bogousslavsky J., Vingerhoets F.J. How do parkinsonian signs return after discontinuation of subthalamic DBS? Neurology. 60:2003;78-81 The authors observed a sequential pattern of return of Parkinsonian signs when the stimulation was turned off. With the tremor worsening within minutes, followed by a smoother slower worsening of bradykinesia and rigidity over half an hour to an hour, and finally a slow and steady worsening of axial signs over 3 to 4 hours. Ninety percent of the UPDRS motor score worsening was reached after 2 hours. After switching STN DBS 'on' again, all motor UPDRS subscores improved with a similar pattern, but faster than their rate of worsening, especially with regards to axial signs. At least 3 hours off STN DBS is needed to estimate the clinical effect of stimulation.
30. De Boer A.G.E.M., Wijker W., Speelman J.D., Dehaes J.C.J.M. Quality of life in patients with Parkinson's disease: development of a questionnaire. J Neurol Neurosurg Psychiatry. 61:1996;70-74.
31. Martinez-Martin P., Valldeoriola F., Tolosa E., Pilleri M., Molinuevo J.L., Rumia J., Ferrer E. Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson's disease. Mov Disord. 17:2002;372-377.
32. Just H., Ostergaard K. Health-related quality of life in patients with advanced Parkinson's disease treated with deep brain stimulation of the subthalamic nuclei. Mov Disord. 17:2002;539-545.
33. Piallat B., Benazzouz A., Benabid A.L. Subthalamic nucleus lesion in rats prevents dopaminergic nigral neuron degeneration after striatal 6-OHDA injection: behavioural and immunohistochemical studies. Eur J Neurosci. 8:1996;1408-1414.
34. Nakao N., Nakai E., Nakai K., Itakura T. Ablation of the subthalamic nucleus supports the survival of nigral dopaminergic neurons after nigrostriatal lesions induced by the mitochondrial toxin 3-nitropropionic acid. Ann Neurol. 45:1999;640-651.
35. Krack P., Kumar R., Ardouin C., Dowsey P.L., McVicker J.M., Benabid A.L., Pollak P. Mirthful laughter induced by subthalamic nucleus stimulation. Mov Disord. 16:2001;867-875 This study reports mirthful laughter induced by STN stimulation, the first case of this type of mood change, and raises the question of where this happens.
36. Bejjani B.P., Damier P., Arnulf I., Thivard L., Bonnet A.M., Dormont D., Cornu P., Pidoux B., Samson Y., Agid Y. Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med. 340:1999;1476-1480.
37. Kumar R., Krack P., Pollak P. Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med. 341:1999;1003-1004.
38. Schneider F., Habel U., Volkmann J., Regel S., Kornischka J., Sturm V., Freund H.J. Deep brain stimulation of the subthalamic nucleus enhances emotional processing in Parkinson's disease. Arch Gen Psychiatry. 60:2003;296-302.
39. Berney A., Vingerhoets F., Perrin A., Guex P., Villemure J.G., Burkhard P.R., Benkelfat C., Ghika J. Effect on mood of subthalamic DBS for Parkinson's disease: a consecutive series of 24 patients. Neurology. 59:2002;1427-1429.
40. Bejjani B.P., Houeto J.L., Hariz M., Yelnik J., Mesnage V., Bonnet A.M., Pidoux B., Dormont D., Cornu P., Agid Y. Aggressive behavior induced by intraoperative stimulation in the triangle of Sano. Neurology. 59:2002;1425-1427.
41. Kulisevsky J., Berthier M.L., Gironell A., Pascual-Sedano B., Molet J., Pares P. Mania following deep brain stimulation for Parkinson's disease. Neurology. 59:2002;1421-1424.
42. Schroeder U., Kuehler A., Haslinger B., Erhard P., Fogel W., Tronnier V.M., Lange K.W., Boecker H., Ceballos-Baumann A.O. Subthalamic nucleus stimulation affects striato-anterior cingulate cortex circuit in a response conflict task: a PET study. Brain. 125:2002;1995-2004.
43. Mayberg H.S., Lozano A.M. Penfield revisited? Understanding and modifying behavior by deep brain stimulation for PD. Neurology. 59:2002;1298-1299.
44. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12:1989;366-375.
45. Alexander G.E., Crutcher M.D. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 13:1990;266-271.
46. Parent A., Hazrati L.N. Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Brain Res Rev. 20:1995;128-154.
47. Carbon M., Eidelberg D. Modulation of regional brain function by deep brain stimulation: studies with positron emission tomography. Curr Opin Neurol. 15:2002;451-455.
48. Dauper J., Peschel T., Schrader C., Kohlmetz C., Joppich G., Nager W., Dengler R., Rollnik J.D. Effects of subthalamic nucleus (STN) stimulation on motor cortex excitability. Neurology. 59:2002;700-706.
49. Sestini S., Scotto di Luzio A., Ammannati F., De Cristofaro M.T., Passeri A., Martini S., Pupi A. Changes in regional cerebral blood flow caused by deep-brain stimulation of the subthalamic nucleus in Parkinson's disease. J Nucl Med. 43:2002;725-732.
50. Benazzouz A., Gao D., Ni Z., Benabid A.L. High frequency stimulation of the STN influences the activity of dopamine neurons in the rat. Neuroreport. 11:2000;1593-1596.
51. Hilker R., Voges J., Ghaemi M., Lehrke R., Rudolf J., Koulousakis A., Herholz K., Wienhard K., Sturm V., Heiss W.D. Deep brain stimulation of the subthalamic nucleus does not increase the striatal dopamine concentration in parkinsonian humans. Mov Disord. 18:2003;41-48 This study and those of Nakajima et al. [52] and Strafella et al. [53] demonstrate that the clinical improvement induced by STN HFS is not due to an increase in dopamine release into the striatum.
52. Nakajima T., Nimura T., Yamaguchi K., Ando T., Itoh M., Yoshimoto T., Shirane R. The impact of stereotactic pallidal surgery on the dopamine D2 receptor in Parkinson disease: a positron emission tomography study. J Neurosurg. 98:2003;57-63.
53. Strafella A.P., Sadikot A.F., Dagher A. Subthalamic deep brain stimulation does not induce striatal dopamine release in Parkinson's disease. Neuroreport. 14:2003;1287-1289.
54. Bergman H., Wichmann T., DeLong M.R. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science. 249:1990;1436-1438.
55. Aziz T.Z., Peggs D., Sambrook M.A., Crossman A.R. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydro- pyridine (MPTP)-induced parkinsonism in the primate. Mov Disord. 6:1991;288-292.
56. Benazzouz A., Gross C., Feger J., Boraud T., Bioulac B. Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. Eur J Neurosci. 5:1993;382-389.
57. Benazzouz A., Piallat B., Pollak P., Benabid A.L. Responses of substantia nigra pars reticulata and globus pallidus complex to high frequency stimulation of the subthalamic nucleus in rats: electrophysiological data. Neurosci Lett. 189:1995;77-80.
58. Benazzouz A., Gao D.M., Ni Z.G., Piallat B., Bouali-Benazzouz R., Benabid A.L. Effect of high-frequency stimulation of the subthalamic nucleus on the neuronal activities of the substantia nigra pars reticulata and ventrolateral nucleus of the thalamus in the rat. Neuroscience. 99:2000;289-295.
59. Beurrier C., Bioulac B., Audin J., Hammond C. High-frequency stimulation produces a transient blockade of voltage-gated currents in subthalamic neurons. J Neurophysiol. 85:2001;1351-1356.
60. Benabid A.L., Henriksen S.J., McGinty J.F., Bloom F.E. Thalamic nucleus ventro-postero-lateralis inhibits nucleus parafascicularis response to noxious stimuli through a non-opioid pathway. Brain Res. 280:1983;217-231.
61. Bikson M., Lian J., Hahn P.J., Stacey W.C., Sciortino C., Durand D.M. Suppression of epileptiform activity by high frequency sinusoidal fields in hippocampal slices. J Physiol. 531:2001;181-189.
62. Garciana L., Audin J., D'Alessandro G., Bioulac B., Hammond C. Dual effect of high frequency stimulation on subthalamic neuron activity. J Neurosci. 23:2003;8743-8751.
63. Do M.T.H., Bean B.P. Subthreshold sodium currents and pacemaking of subthalamic neurons: modulation by slow inactivation. Neuron. 39:2003;109-120.
64. Vitek J.L. Deep brain stimulation for Parkinson's disease. A critical re-evaluation of STN versus GPi DBS. Stereotact Funct Neurosurg. 78:2002;119-131.
65. LePen C., Wait S., Moutard-Martin F., Dujardin M., Ziegler M. Cost of illness and disease severity in a cohort of French patients with Parkinson's disease. Pharmacoeconomics. 16:1999;59-69.
66. Tasker R.R., Siqueira J., Hawrylyshyn P., Organ L.W. What happened to VIM thalamotomy for Parkinson's disease? Appl Neurophysiol. 46:1983;68-83.
67. Laitinen L.V., Bergenheim A.T., Hariz M.I. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg. 76:1992;53-61.
68. Tronnier V.M., Fogel W., Kronenbuerger M., Steinvorth S. Pallidal stimulation: an alternative to pallidotomy? J Neurosurg. 87:1997;700-705.
69. Loher T.J., Burgunder J.M., Pohle T., Weber S., Sommerhalder R., Krauss J.K. Long-term pallidal deep brain stimulation in patients with advanced Parkinson disease: 1-year follow-up study. J Neurosurg. 96:2002;844-853.
70. •] have been the promoters of subthalamotomy as a treatment for advanced PD. Although they have not reported data suggesting that subthalamotomy should replace STN DBS, their data provide one more example of a structure in which lesion effects are mimicked by HFS.
71. Alvarez L., Macias R., Guridi J., Lopez G., Alvarez E., Maragoto C., Teijeiro J., Torres A., Pavon N., Rodriguez-Oroz M.C.et al. Dorsal subthalamotomy for Parkinson's disease. Mov Disord. 16:2001;72-78 In 11 patients that were followed-up for at least 12 months after dorsal subthalamotomy, daily levodopa equivalents were unchanged in 10 patients, and both UPDRS parts II and III in the 'off' state were significantly reduced for up to 24 months in 4 patients. The dyskinesia score did not change postoperatively. Lesion-induced dyskinesias were not a management problem except for those in one patient, who developed a large infarction several days postsurgery. The authors therefore consider that subthalamotomy could be another surgical option under specific circumstances, as it is not generally associated with hemiballismus and may give considerable motor benefit.
72. Doshi P.K., Chhaya N., Bhatt M.H. Depression leading to attempted suicide after bilateral subthalamic nucleus stimulation for Parkinson's disease. Mov Disord. 17:2002;1084-1085.
73. Chen C.C., Lee S.T., Wu T., Chen C.J., Huang C.C., Lu C.S. Hemiballism after subthalamotomy in patients with Parkinson's disease: report of 2 cases. Mov Disord. 17:2002;1367-1371.
74. Su P.C., Tseng H.M., Liu H.M., Yen R.F., Liou H.H. Treatment of advanced Parkinson's disease by subthalamotomy: one-year results. Mov Disord. 18:2003;531-538.
75. Lindvall O., McKay R. Brain repair by cell replacement and regeneration. Proc Natl Acad Sci USA. 100:2003;7430-7431 Neural graft has been considered for decades as the most elegant prospective for treatment of PD and other degenerative diseases. The fact that this therapy is currently unavailable is a result of several difficulties, whose solutions are outlined in this paper by the most thoughtful researchers in the field.
76. Bensadoun J.C., Pereira de Almeida L., Fine E.G., Tseng J.L., Deglon N., Aebischer P. Comparative study of GDNF delivery systems for the CNS: polymer rods, encapsulated cells, and lentiviral vectors. J Control Release. 87:2003;107-115 The authors discuss the fact that encapsulated cells constitute a totally new approach for local delivery of molecules to brain targets, and suggest that they may provide solutions for the neural graft problems.
77. Gill S.S., Patel N.K., Hotton G.R., O'Sullivan K., McCarter R., Bunnage M., Brooks D.J., Svendsen C.N., Heywood P. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson's disease. Nat Med. 9: 2003;589-595 The authors report the first long-term results of an experimental clinical trial in advanced PD. If these results are confirmed and improved, the method could be a strong challenger of DBS techniques in PD and other neurodegenerative diseases.
78. Luo J., Kaplitt M.G., Fitzsimons H.L., Zuzga D.S., Liu Y., Oshinsky M.L., During M.J. Subthalamic GAD gene therapy in a Parkinson's disease rat model. Science. 298:2002;425-429 The authors demonstrate experimentally that gene therapy might totally change the functional profile of a neural structure, and make it perform the opposite of its known function. The authors strongly support their working hypothesis, and it is at the basis of a current clinical trial. In theory, such a principle might provide the ultimate new tools for functional neurosurgery.
79. Lanotte M.M., Rizzone M., Bergamasco B., Faccani G., Melcarne A., Lopiano L. Deep brain stimulation of the subthalamic nucleus: anatomical, neurophysiological, and outcome correlations with the effects of stimulation. J Neurol Neurosurg Psychiatry. 72:2002;53-58.
80. Saint-Cyr J.A., Hoque T., Pereira L.C., Dostrovsky J.O., Hutchison W.D., Mikulis D.J., Abosch A., Sime E., Lang A.E., Lozano A.M. Localization of clinically effective stimulating electrodes in the human subthalamic nucleus on magnetic resonance imaging. J Neurosurg. 97:2002;1152-1166.
81. Benabid A.L., Minotti L., Koudsie A., de Saint Martin A., Hirsch E. Antiepileptic effect of high-frequency stimulation of the subthalamic nucleus (corpus luysi) in a case of medically intractable epilepsy caused by focal dysplasia: a 30-month follow-up: technical case report. Neurosurgery. 50:2002;1385-1391 This is the first clinical demonstration that STN functional inhibition by HFS might be used as a treatment for pharmaco-resistent epilepsies.
82. Chabardes S., Kahane P., Minotti L., Koudsie A., Hirsch E., Benabid A.L. Deep brain stimulation in epilepsy with particular reference to the subthalamic nucleus. Epileptic Disord. 4:2002;83-93.
83. Nuttin B., Cosyns P., Demeulemeester H., Gybels J., Meyerson B. Electrical stimulation in anterior limbs of internal capsules in patients with obsessive-compulsive disorder. Lancet. 354:1999;1526.
84. Mallet L., Mesnage V., Houeto J.L., Pelissolo A., Yelnik J., Behar C., Gargiulo M., Welter M.L., Bonnet A.M., Pillon B.et al. Compulsions, Parkinson's disease, and stimulation. Lancet. 360:2002;1302-1304.
85. Franzini A., Ferroli P., Leone M., Broggi G. Stimulation of the posterior hypothalamus for treatment of chronic intractable cluster headaches: first reported series. Neurosurgery. 52:2003;1095-1099 The authors report that, following data provided by PET studies in cluster headaches, DBS at HFS was successfully tried in the posterior hypothalamus to treat severe forms of this disease.
86. Benabid A.L., Vercueil L., Benazzouz A., Koudsie A., Chabardes S., Minotti L., Kahane P., Gentil M., Lenartz D., Andressen C.et al. Deep brain stimulation: what does it offer? Adv Neurol. 91:2003;293-302.
87. Groenewegen H.J., Berendse H.W. Connections of the subthalamic nucleus with ventral striatopallidal parts of the basal ganglia in the rat. J Comp Neurol. 294:1990;607-622.